{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T16:18:46Z","timestamp":1648657126839},"reference-count":21,"publisher":"Wiley","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2038,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1111\/j.1600-0714.2009.00885.x","type":"journal-article","created":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T05:07:31Z","timestamp":1267420051000},"source":"Crossref","is-referenced-by-count":1,"title":["Celecoxib enhances the inhibitory effect of cisplatin on Tca8113 cells in human tongue squamous cell carcinoma<i>in vivo<\/i>and<i>in vitro<\/i>"],"prefix":"10.1111","author":[{"given":"Wei Zhong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao Yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zu Guo","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan Qing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB1","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jtherbio.2005.11.008","article-title":"Cyclooxygenase: past, present and future. A tribute to John R. Vane (1927-2004)","volume":"31","author":"Botting","year":"2002","journal-title":"J Therm Biol"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1007\/s00428-002-0616-y","article-title":"Expression of cyclo-oxygenase-2 in human tongue carcinoma and its precursor lesions","volume":"440","author":"Renkonen","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB3","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0002-9440(10)64586-5","article-title":"Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions","volume":"157","author":"Sung","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0169-5002(00)00132-X","article-title":"Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung","volume":"30","author":"Hosomi","year":"2000","journal-title":"Lung Cancer"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB5","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.critrevonc.2006.01.003","article-title":"Cyclooxygenase-2 as a target for anticancer drug development","volume":"59","author":"M\u00e9ric","year":"2006","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB6","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.ijrobp.2006.09.055","article-title":"Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis","volume":"67","author":"Kang","year":"2007","journal-title":"Int J Radiation Oncology Biol Phys"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.radonc.2006.11.018","article-title":"Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro","volume":"82","author":"Ohneseit","year":"2007","journal-title":"Radiother Oncol"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB8","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/S0149-2918(00)80005-3","article-title":"Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis","volume":"21","author":"Goldenberg","year":"1999","journal-title":"Clin Ther"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(91)90198-O","article-title":"A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry","volume":"139","author":"Nicoletti","year":"1991","journal-title":"J Immunol Methods"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB10","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1097\/01.ju.0000131945.74377.ad","article-title":"Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522","volume":"172","author":"Mizutani","year":"2004","journal-title":"J Urol"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB11","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.phrs.2004.04.002","article-title":"The potential role of cyclooxygenase-2 inhibitors in the treatment of experimentally-induced mammary tumour: does celecoxib enhance the anti-tumour activity of doxorubicin?","volume":"50","author":"Awara","year":"2004","journal-title":"Pharmacol Res"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB12","first-page":"665","article-title":"Apoptosis induction and enhancement of cytotoxicity of anticancer drugs by celecoxib, a selective cyclooxygenase-2 inhibitor, in human head and neck carcinoma cell line","volume":"23","author":"Hashitani","year":"2003","journal-title":"Int J Oncol"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB13","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ijrobp.2005.06.007","article-title":"Inhibition of DNA repair as a mechanism of enhanced radioresponse of head and neck carcinoma cells by a selective cyclooxygenase-2 inhibitor, celecoxib","volume":"63","author":"Raju","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB14","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10637-006-9016-5","article-title":"A phase I\/II trial of celecoxib with chemotherapy and radiotherapy in the treatment of patients with locally advanced oesophageal cancer","volume":"25","author":"Dawson","year":"2007","journal-title":"Invest New Drugs"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB15","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3748\/wjg.v13.i13.1947","article-title":"Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells","volume":"13","author":"Lim","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB16","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bcp.2005.05.028","article-title":"Combination of cyclooxygenase-2 inhibitors and oxaliplatin increases the growth inhibition and death in human colon cancer cells","volume":"70","author":"Lin","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.biopha.2007.02.011","article-title":"Synergistic effects of meloxicam and conventional cytotoxic drugs in human MG-63 osteosarcoma cells","volume":"61","author":"Naruse","year":"2007","journal-title":"Biomed Pharmacother"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejca.2006.09.010","article-title":"Celecoxib enhances doxorubicin-induced cytotoxicity in MDA-MB231 cells by NF-kappaB-mediated increase of intracellular doxorubicin accumulation","volume":"43","author":"van Wijngaarden","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00280-007-0462-3","article-title":"A comparison of the effectiveness of selected non-steroidal anti-inflammatory drugs and their derivatives against cancer cells in vitro","volume":"61","author":"Andrews","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB20","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1158\/1535-7163.MCT-05-0139","article-title":"Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells","volume":"4","author":"Kang","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1111\/j.1600-0714.2009.00885.x-BIB21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.104.071571","article-title":"Impact of the cyclooxygenase system on doxorubicin-induced functional multidrug resistance 1 overexpression and doxorubicin sensitivity in acute myeloid leukemic HL-60 cells","volume":"312","author":"Puhlmann","year":"2005","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Journal of Oral Pathology &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0714.2009.00885.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1600-0714.2009.00885.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,7]],"date-time":"2021-07-07T11:05:08Z","timestamp":1625655908000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0714.2009.00885.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":21,"URL":"https:\/\/doi.org\/10.1111\/j.1600-0714.2009.00885.x","relation":{},"ISSN":["0904-2512","1600-0714"],"issn-type":[{"value":"0904-2512","type":"print"},{"value":"1600-0714","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}